AIDPATH is a high-energy EU consortium, dedicated to enable and to augment the next-generation of personalized medicine with gene-engineered immune cells at EU hospitals through the use of AI technology. The exemplary embodiment of gene-engineered immune cells in AIDPATH will be T cells modified to express a synthetic chimeric antigen receptor (CAR-T) that are already a revolution-ary novel treatment in hematology and oncology. AIDPATH will apply top-notch AI technology to integrate patient-specific data and biomarkers in CAR-T therapy and to optimize scheduling and resource planning to reduce cost and hospital resource utilization. The consortium members are well-positioned to engage into a productive dialogue with regulators and patients to ensure acceptance and rapid adoption by EU hospitals and industry.
Company Details
- Address
- Steinbachstraße 17, Aachen,nordrhein-Westfalen 52074,germany
- Industry
- Research
- Website
- http://aidpath-project.eu
- Keywords
- GETAFE.
- HQ
- Aachen, Nordrhein-Westfalen
Aidpath Questions
Aidpath's website is http://aidpath-project.eu
Aidpath's LinkedIn profile is https://de.linkedin.com/company/aidpath
Aidpath's industry is
Research
Aidpath's top competitors are
Chondropeptix,
Deliver Biosciences,
Crew Uk,
Nederlands Hart Netwerk,
Fraunhofer Institute For Production Technology Ipt,
Glorifarm Biosciences,
Aglaris Cell Sl,
Tasting With Nivard,
Aglaris,
Ori Biotech.
Aidpath's categories are Research
